Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study-Reference-Cited by-同舟云学术

Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study

Published:2024-03 Issue: Volume:36 Page:200-209
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Morata Ruiz Laura,Ruggieri Alessandro,Falcone Marco,Pasquau Liaño Juan,Gentile Ivan,Salavert Lletí Miguel^ORCID,Moreno Núñez Leonor,Cascio Antonio^ORCID,Tascini Carlo,Loeches Yagüe Maria^ORCID,De Rosa Francesco Giuseppe,Ori Alessandra,Comandini Alessandro,Cattaneo Agnese,Grossi Paolo Antonio

Publisher

Elsevier BV

Reference46 articles.

1. IDF Diabetes Atlas. Available at: https://diabetesatlas.org/#:∼:text=Diabetes%20around%20the%20world%20in%202021%3A,%2D%20and%20middle%2Dincome%20countries. Accessed February 6, 2023.

2. The diabetes pandemic and associated infections: suggestions for clinical microbiology;Toniolo;Rev Med Microbiol,2019

3. The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis;Stacey;Acta Diabetol,2019

4. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study;Carey;Diabetes Care,2018

5. Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies;Akash;Arch Microbiol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry;Journal of Global Antimicrobial Resistance;2024-09